Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1

  • Babak Jahangiri
  • Mohammad Khalaj-kondoriEmail author
  • Elahe Asadollahi
  • Majid Sadeghizadeh
Research Article


Cancer-associated fibroblasts (CAFs) have been considered as major players in tumor growth and malignancy. In colorectal cancer (CRC), CAFs are attendance in high affluence and little is known about how they impact tumor progression. An increasing number of studies indicated that dysregulation of human urothelial carcinoma associated 1 (UCA1) is associated with progression of tumor and metastasis in various cancers including CRC. Nonetheless, the possible mechanisms of UCA1 actuation in CRC remain poorly understood. To address this, we elucidated the effects of conditioned medium from SW480 CRC cells/Normal fibroblast co-culture (CAF-CM) on UCA1 expression, and the cell proliferation, EMT, invasion and migration of the treated CRC cell were evaluated in vitro. Our study indicated that CAFs dramatically stimulated cell proliferation and migration of CRC cell. Furthermore, CAFs induced the EMT phenotype in CRC cell, with an associated change in the expression of EMT markers including vimentin, E-cadherin, N-cadherin and metastasis-related genes (MMPs). Moreover, we found an increased percentage of CRC cell in the S and G2/M phase induced by CAFs. Our results revealed that CAFs could induce upregulation of UCA1, leading to upregulation of mTOR. Up-regulation of UCA1/mTOR axis suppressed p27 and miR-143 while the expression of Cyclin-D1 and KRAS were significantly increased compared with control. Furthermore, UCA1 silencing in treated CRC cell suggested that upregulation of UCA1, which was induced by CAFs, regulates the expression of downstream key effectors. Taken together, these results highlight the vital role of cooperation between lncRNA UCA1 and mTOR in proliferation and metastasis which support the hypothesis that CAFs may be a prominent therapeutic target of stroma-based therapy in CRC treatment.


Cancer-associated fibroblasts (CAFs) lncRNA UCA1 mTOR KRAS miR-143 Colorectal cancer 



Cancer-associated fibroblasts


Cancer-associated fibroblasts conditioned medium


Colorectal cancer cell


Dimethyl sulfoxide


Epithelial-to-mesenchymal transition


Long noncoding RNA


Matrix metalloproteinases


Normal fibroblasts conditioned medium


Quantitative reverse transcription–polymerase chain reaction


Urothelial carcinoma associated 1


Small interfering RNA


Transcription factors



This work was supported by the research deputy of University of Tabriz.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflicts of interest.


  1. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y, Naoe T (2010) Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 17:398CrossRefGoogle Scholar
  2. Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointestinal cancer research: GCR 5:19Google Scholar
  3. Augsten M (2014) Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol:4Google Scholar
  4. Balk SP, Knudsen KE (2008) AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6Google Scholar
  5. Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, Feng Y, Liu H, Fei B, Mao Y (2016) LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6Google Scholar
  6. Boutin AT, Liao W-T, Wang M, Hwang SS, Karpinets TV, Cheung H, Chu GC, Jiang S, Hu J, chang k (2017) Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes Dev 31:370–382CrossRefPubMedCentralGoogle Scholar
  7. Cao Y, Liu X, Lu W, Chen Y, Wu X, Li M, Wang X-A, Zhang F, Jiang L, Zhang Y (2015) Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer. Cancer Lett 360:141–150CrossRefGoogle Scholar
  8. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28:1385CrossRefGoogle Scholar
  9. Cheng N, Cai W, Ren S, Li X, Wang Q, Pan H, Zhao M, Li J, Zhang Y, Zhao C (2015) Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer. Oncotarget 6:23582PubMedCentralGoogle Scholar
  10. Conti J, Thomas G (2011) The role of tumour stroma in colorectal cancer invasion and metastasis. Cancers 3:2160–2168CrossRefPubMedCentralGoogle Scholar
  11. de Wever O, Van Bockstal M, Mareel M, Hendrix A, Bracke M (2014) Carcinoma-associated fibroblasts provide operational flexibility in metastasis. Semin Cancer Biol:33–46Google Scholar
  12. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, seeff l C (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573CrossRefPubMedCentralGoogle Scholar
  13. Faivre S, Kroemer G, Raymond E (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5:671–688CrossRefGoogle Scholar
  14. Fang JY, Richardson BC (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6:322–327CrossRefGoogle Scholar
  15. Fang Y, Bao W, Rao Q, Wang X, Xia Q, Shen Q, Zhou X, Yao B (2017) TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway. Mol Med Rep 16:2721–2725CrossRefPubMedCentralGoogle Scholar
  16. Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H (2014) Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 117:89–95CrossRefGoogle Scholar
  17. Francipane MG, Lagasse E (2014) mTOR pathway in colorectal cancer: an update. Oncotarget 5:49CrossRefGoogle Scholar
  18. Gandellini P, Andriani F, Merlino G, D’aiuto F, Roz L, Callari M (2015) Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types. Semin Cancer Biol:96–106Google Scholar
  19. Gonda TA, Varro A, Wang TC, Tycko B (2010) Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy. Semin Cell Dev Biol:2–10Google Scholar
  20. Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'connor KL, Gao T (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71:3246–3256CrossRefPubMedCentralGoogle Scholar
  21. Han Y, Yang Y-N, Yuan H-H, Zhang T-T, Sui H, Wei X-L, Liu L, Huang P, Zhang W-J, Bai Y-X (2014) UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 46:396–401CrossRefGoogle Scholar
  22. Han Y, Zhang Y, Jia T, Sun Y (2015) Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts. Tumor Biol 36:1385–1394CrossRefGoogle Scholar
  23. He Z, Wang Y, Huang G, Wang Q, Zhao D, Chen L (2017) The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Arch Biochem Biophys 623:1–8CrossRefGoogle Scholar
  24. Herrera M, Islam AB, Herrera A, Martín P, García V, Silva J, Garcia JM, Salas C, Casal I, de Herreros AG (2013) Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res 19:5914–5926CrossRefGoogle Scholar
  25. Hollander MC, Blumenthal GM, Dennis PA (2011) PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11:289CrossRefGoogle Scholar
  26. Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace r, Slingerland JM (2008) mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 30:701–711CrossRefGoogle Scholar
  27. Hong H-H, Hou L-K, Pan X, Wu C-Y, Huang H, Li B, Nie W (2016) Long non-coding RNA UCA1 is a predictive biomarker of cancer. Oncotarget 7:44442PubMedCentralGoogle Scholar
  28. Hu J-J, Song W, Zhang S-D, Shen X-H, Qiu X-M, Wu H-Z, Gong P-H, Lu S, Zhao Z-J, He M-L (2016) HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep 6:23521CrossRefPubMedCentralGoogle Scholar
  29. Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo Y (2014) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5:e1008CrossRefPubMedCentralGoogle Scholar
  30. Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo Y (2015) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5:e1008CrossRefGoogle Scholar
  31. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y (2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15:195–206CrossRefGoogle Scholar
  32. Kulda V, Pesta M, Topolcan O, liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L (2010) Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 200:154–160CrossRefGoogle Scholar
  33. Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W (2015) miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget 6:24448PubMedCentralGoogle Scholar
  34. Li W, Zhang X, Wang J, Li M, Cao C, Tan J, Ma D, Gao Q (2017) TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells. Oncotarget 8:96035PubMedCentralGoogle Scholar
  35. Li Z, Li X, Wu S, Xue M, Chen W (2014) Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway. Cancer Sci 105:951–955CrossRefPubMedCentralGoogle Scholar
  36. Madar S, Goldstein I, Rotter V (2013) ‘Cancer associated fibroblasts’–more than meets the eye. Trends Mol Med 19:447–453CrossRefGoogle Scholar
  37. Michor F, Iwasa Y, Lengauer C, Nowak MA (2005) Dynamics of colorectal cancer. Semin Cancer Biol:484–493Google Scholar
  38. Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P, Yuan Z, Deng Y, Wang J, Chen D (2015) Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 47:1329–1338CrossRefGoogle Scholar
  39. Organization WH (2017) World health statistics 2016: monitoring health for the SDGs, sustainable development goals. 2016. WHO Library Cataloguing-in-Publication Data, GenevaGoogle Scholar
  40. Patel JS, Hu M, Sinha G, Walker ND, Sherman LS, Gallagher A, Rameshwar P (2016) Non-coding RNA as mediators in microenvironment–breast cancer cell communication. Cancer Lett 380:289–295CrossRefGoogle Scholar
  41. Paulsson J, Micke P (2014) Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol:61–68Google Scholar
  42. Schwaederlé M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R (2015) Cyclin alterations in diverse cancers: Outcome and co-amplification network. Oncotarget 6:3033CrossRefGoogle Scholar
  43. Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW (2014) KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158:171–184CrossRefPubMedCentralGoogle Scholar
  44. Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers 7:2443–2458CrossRefPubMedCentralGoogle Scholar
  45. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177–193CrossRefGoogle Scholar
  46. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72:397–402CrossRefGoogle Scholar
  47. Soon PS, Kim E, Pon CK, Gill AJ, Moore K, Spillane AJ, Benn DE, Baxter RC (2013) Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocr Relat Cancer 20:1–12CrossRefGoogle Scholar
  48. Steinbichler TB, Metzler V, Pritz C, Riechelmann H, Dudas J (2016) Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells. Oncotarget 7:2508CrossRefGoogle Scholar
  49. Toker A (2008) mTOR and Akt signaling in cancer: SGK cycles in. Mol Cell 31:6–8CrossRefGoogle Scholar
  50. Tommelein J, Verset L, Boterberg T, Demetter P, Bracke M, de Wever O (2015) Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer Frontiers in oncology:5Google Scholar
  51. Tuo Y, Li X, Luo J (2015) Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci 19:3403–3411Google Scholar
  52. Wang F, Li X, Xie X, Zhao L, Chen W (2008) UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582:1919–1927CrossRefGoogle Scholar
  53. Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904–914CrossRefPubMedCentralGoogle Scholar
  54. Wang L, Cao L, Wang H, Liu B, Zhang Q, Meng Z, Wu X, Zhou Q, Xu K (2017a) Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway. Oncotarget 8:76116PubMedCentralGoogle Scholar
  55. Wang X-S, Zhang Z, Wang H-C, Cai J-L, Xu Q-W, Li M-Q, Chen Y-C, Qian X-P, Lu T-J, Yu L-Z (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12:4851–4858CrossRefGoogle Scholar
  56. Wang Y-H, Wang F, Zhang L, Lu J-C (2017b) Long non-coding RNA UCA1 can predict tumor lymph node metastasis. Tumor Biol 39(1010428317706208)Google Scholar
  57. Wang Z-Q, Cai Q, Hu L, He C-Y, Li J-F, Quan Z-W, Liu B-Y, Li C, Zhu Z-G (2017c) Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death Dis 8:e2839CrossRefPubMedCentralGoogle Scholar
  58. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N (2011) miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem 350:207–213CrossRefGoogle Scholar
  59. Xue M, Chen W, Li X (2016) Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol 142:1407–1419CrossRefGoogle Scholar
  60. Zhang Y, Huang B, Wang H-Y, Chang A, Zheng XS (2017) Emerging Role of MicroRNAs in mTOR Signaling. Cell Mol Life Sci:1–13Google Scholar

Copyright information

© The International CCN Society 2018

Authors and Affiliations

  • Babak Jahangiri
    • 1
    • 2
  • Mohammad Khalaj-kondori
    • 1
    Email author
  • Elahe Asadollahi
    • 3
  • Majid Sadeghizadeh
    • 2
  1. 1.Department of Biological Sciences, Faculty of Natural ScienceUniversity of TabrizTabrizIran
  2. 2.Department of Molecular Genetics, Faculty of Biological SciencesTarbiat Modares UniversityTehranIran
  3. 3.Protein Research CenterShahid Behshti University, G.CTehranIran

Personalised recommendations